TherapeuticsMD
TXMD
TXMD
41 hedge funds and large institutions have $3.78M invested in TherapeuticsMD in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
-1
Holders Change %
-2.38%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
9
Closed
2
Calls
$64K
Puts
–
Net Calls
+$64K
Net Calls Change
+$52K
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
+$5.02K |
2 |
Renaissance Technologies
New York
|
+$1.62K |
3 |
Raymond James Financial
St Petersburg,
Florida
|
+$617 |
4 |
Citigroup
New York
|
+$235 |
5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$46 |
Top Sellers
1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$70.7K |
2 |
Ameriprise
Minneapolis,
Minnesota
|
-$20.8K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.41K |
4 |
TSS
Two Sigma Securities
New York
|
-$3.17K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.04K |